Patents by Inventor Nelly Corine Moore

Nelly Corine Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinazoline compounds with therapeutic use
    Patent number: 7223756
    Abstract: The invention concerns the use of the quinazoline derivatives of Formula (I) wherein each of m, R1, Z, n and R3 have any of the meanings defined in the description in the manufacture of a medicament for use in the prevention or treatment of T cell mediated diseases or medical conditions in a warm-blooded animal
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: May 29, 2007
    Assignee: AstraZeneca AB
    Inventors: Nelly Corine Moore, Keith Oldham
  • Quinazoline derivatives for the treatment of T cell mediated diseases
    Patent number: 7160891
    Abstract: The invention concerns the use of the quinazoline derivatives of Formula (I) wherein each of Q1, Z, m, R1, R2, R3 and Q2 have any of the meanings defined in the description in the manufacture of a medicament for use in the prevention or treatment of T cell mediated diseases or medical conditions in a warm-blooded animal
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: January 9, 2007
    Assignee: AstraZeneca AB
    Inventors: Nelly Corine Moore, Keith Oldham
  • Therapeutic use
    Patent number: 7157467
    Abstract: The invention concerns the use of the quinazoline derivatives of Formula (I) Wherein each of m, R1, n, R2 and R3 have any of the meanings defined in the description in the manufacture of a medicament for use in the prevention or treatment of T cell mediated diseases or medical conditions such as autoimmune diseases like transplant rejection or rheumatoid arthritis in a warm-blooded animal.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: January 2, 2007
    Assignee: AstraZeneca AB
    Inventors: Nelly Corine Moore, Keith Oldham